Angiosarcoma cutáneo de párpado

Quispe-Juli, Cender Udai.
Rev. Cuerpo Méd. Hosp. Nac. Almanzor Aguinaga Asenjo ; 9(2): 138-139, Jun 30, 2016.
Artículo en Español | LILACS-Express | ID: biblio-1053272

Documentos relacionados

  1. Malignant Conversion of Eyelid Capillary Hemangioma to Cutaneous Angiosarcoma.
  2. Cutaneous angiosarcoma presenting as bilateral periorbital edema.
  3. Cutaneous Angiosarcoma Subtypes: A Quantitative Systematic Review of Demographics, Treatments, and Outcomes Within Published Patient-Level Cases.
  4. Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study.
  5. High-dose planned adaptive helical tomotherapy for cutaneous angiosarcoma of the scalp.
  6. OER-073: A multicenter phase 2 study evaluating the role of pazopanib in angiosarcoma.
  7. An uncommon presentation of a cutaneous angiosarcoma.
  8. Plasminogen activating inhibitor-1 promotes angiogenesis in cutaneous angiosarcomas.
  9. An Extensive Presentation of Cutaneous Angiosarcoma.
  10. Atypical presentation of cutaneous angiosarcoma: review of the literature.